Thomas Kronbach

3.1k total citations · 2 hit papers
37 papers, 2.6k citations indexed

About

Thomas Kronbach is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Thomas Kronbach has authored 37 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 16 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Thomas Kronbach's work include Pharmacogenetics and Drug Metabolism (21 papers), Drug Transport and Resistance Mechanisms (8 papers) and Phosphodiesterase function and regulation (7 papers). Thomas Kronbach is often cited by papers focused on Pharmacogenetics and Drug Metabolism (21 papers), Drug Transport and Resistance Mechanisms (8 papers) and Phosphodiesterase function and regulation (7 papers). Thomas Kronbach collaborates with scholars based in Switzerland, Germany and United States. Thomas Kronbach's co-authors include Urs Meyer, Volker Fischer, Frank J. Gonzalez, Pierre Dayer, J. Gut, Josef Gut, U. Thomas Meier, Eric F. Johnson, Michel Eichelbaum and Eric F. Johnson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Thomas Kronbach

37 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.

1989 481 citations Thomas Kronbach, Urs Meyer et al. Molecular Pharmacology profile →
Cyclosporine metabolism in human liver: Identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs

1988 465 citations Thomas Kronbach, Volker Fischer et al. Clinical Pharmacology & Therapeutics profile →

Peers

Countries citing papers authored by Thomas Kronbach

Since Specialization

Citations

This map shows the geographic impact of Thomas Kronbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kronbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kronbach more than expected).

Fields of papers citing papers by Thomas Kronbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kronbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kronbach. The network helps show where Thomas Kronbach may publish in the future.

Co-authorship network of co-authors of Thomas Kronbach

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kronbach. A scholar is included among the top collaborators of Thomas Kronbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kronbach. Thomas Kronbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In Vivo Efficacy in Airway Disease Models of N-(3,5-Dichloropyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic Acid Amide (AWD 12-281), a Selective Phosphodiesterase 4 Inhibitor for Inhaled Administration 2003 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), (unknown), Sarah Johanssen, Thomas Kronbach, Chris Rundfeldt	68
2	Refolding and Purification of Recombinant Human PDE7A Expressed in Escherichia coli as Inclusion Bodies 2002 ·Protein Expression and Purification ·Wito Richter, Thomas Hermsdorf, Thomas Kronbach, D Dettmer	11
3	AWD 12-281 2002 ·Drugs of the Future ·(unknown), (unknown), Ute Egerland, (unknown), (unknown), Istvan Szelenyi, (unknown), (unknown), Martin Olbrich, (unknown), (unknown), (unknown), (unknown), Thomas Kronbach, (unknown)	5
4	Morpholine ring oxidation of AWD 131-138, a novel anxiolytic and anticonvulsant, is catalysed by CYP1A1/2. 2001 ·Drug Metabolism Reviews ·(unknown), (unknown), Martin Olbrich, (unknown), (unknown), Róbert Hermann, Thomas Kronbach	2
5	Identification of inhibitor binding sites of the cAMP-specific phosphodiesterase 4 2001 ·Cellular Signalling ·Wito Richter, (unknown), Thomas Hermsdorf, Thomas Kronbach, D Dettmer	19
6	Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis 2001 ·Cellular Signalling ·Wito Richter, (unknown), Thomas Hermsdorf, Thomas Kronbach, D Dettmer	12
7	New metabolic pathways of alpha-lipoic acid. 2001 ·PubMed ·(unknown), (unknown), G. Peter, Róbert Hermann, Klaus Wessel, J. Engel, Thomas Kronbach	63
8	Refolding, Purification, and Characterization of Human Recombinant PDE4A Constructs Expressed in Escherichia coli 2000 ·Protein Expression and Purification ·Wito Richter, Thomas Hermsdorf, Hauke Lilie, Ute Egerland, Rainer Rudolph, Thomas Kronbach, D Dettmer	12
9	Metabolism of Retigabine (D-23129), a Novel Anticonvulsant 1999 ·Drug Metabolism and Disposition ·(unknown), (unknown), (unknown), (unknown), (unknown), Christian Grunwald, Gottfried Zimmermann, Christian Griesinger, Jürgen Engel, Thomas Kronbach	77
10	Retigabine N-Glucuronidation and Its Potential Role in Enterohepatic Circulation 1999 ·Drug Metabolism and Disposition ·(unknown), Nghia Nguyen, Christian P. Strassburg, Qing Li, (unknown), (unknown), Peter Ruus, Jürgen Engel, Robert H. Tukey, Thomas Kronbach	70
11	AWD-131-138 1998 ·Drugs of the Future ·A Rostock, C. Tober, Rita Dost, Chris Rundfeldt, (unknown), Ute Egerland, (unknown), (unknown), Thomas Kronbach, Hans‐Joachim Lankau, Klaus Unverferth, J. Engel	18
12	Purification and Characterization of Recombinant-Expressed Cytochrome P450 2C3 from Escherichia coli: 2C3 Encodes the 6β-Hydroxylase Deficient Form of P450-3b 1993 ·Archives of Biochemistry and Biophysics ·Toby H. Richardson, Mei‐Hui Hsu, Thomas Kronbach, Henry Barnes, Raquel L. Chan, Michael R. Waterman, B. Kemper, Eric F. Johnson	40
13	[49] Bufuralol, dextromethorphan, and debrisoquine as prototype substrates for human P450IID6 1991 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Thomas Kronbach	52
14	A hypervariable region of P450IIC5 confers progesterone 21-hydroxylase activity to P450IIC1 1991 ·Biochemistry ·Thomas Kronbach, Byron Kemper, Eric F. Johnson	42
15	Properties of Expressed and Native Flavin-Containing Monooxygenases: Evidence of Multiple Forms in Rabbit Liver and Lung 1991 ·Molecular Pharmacology ·Michael Lawton, Thomas Kronbach, Eric F. Johnson, R.M. Philpot	26
16	In vitro characterization of the human cytochrome P-450 involved in polymorphic oxidation of propafenone 1989 ·Clinical Pharmacology & Therapeutics ·Heyo K. Kroemer, Gerd Mikus, Thomas Kronbach, Urs Meyer, Michel Eichelbaum	71
17	Cyclosporine metabolism in human liver: Identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs breakdown → 1988 ·Clinical Pharmacology & Therapeutics ·Thomas Kronbach, Volker Fischer, Urs Meyer	465
18	Enzymatic basis of the debrisoquine/sparteine-type genetic polymorphism of drug oxidation 1987 ·Biochemical Pharmacology ·Pierre Dayer, Thomas Kronbach, Michel Eichelbaum, (unknown)	56
19	Stereo- and regioselectivity of hepatic oxidation in man ? Effect of the debrisoquine/sparteine phenotype on bufuralol hydroxylation 1986 ·European Journal of Clinical Pharmacology ·Pierre Dayer, T. Leemann, A Küpfer, Thomas Kronbach, Urs Meyer	34
20	Klassische Synthese von Thymopoietin 32-36 (TP 5) unter Verwendung der säurelabilen 1- (1 -Adamantyl) -1 -methylethoxycarbonyl- Schutzgruppe+ / Conventional Synthesis of Thymopoietin 32-36 (TP 5) Using the 1 -(1 - Adamantyl)-1 -methylethoxycarbonyl Group 1982 ·Zeitschrift für Naturforschung B ·(unknown), Thomas Kronbach, Wolfgang Voelter	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact